about
Coping strategies in patients with acquired brain injury: relationships between coping, apathy, depression and lesion locationParkinson's disease and REM sleep behavior disorder result in increased non-motor symptoms.Treatment of Depression in the Patient with Parkinson's Disease.Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).Clinical correlates of depressive symptoms in familial Parkinson's disease.Parkinson's disease: the quintessential neuropsychiatric disorderThe role of depression severity in the cognitive functioning of elderly subjects with central nervous system disease.Extrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly.Major depressive disorder in Parkinson's disease: a cross-sectional study from Sri LankaManagement of Parkinson's disease. Strategies, pitfalls, and future directions.Psychiatric aspects of Parkinson's disease.Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease.The Natural History of Depression in Parkinson's Disease within 30-Month Follow-Up.Neuropsychiatric aspects of Parkinson's disease: recent advances.Range of neuropsychiatric disturbances in patients with Parkinson's disease.Depression in Parkinson's disease: conceptual issues and clinical challenges.Antidepressant studies in Parkinson's disease: a review and meta-analysis.Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease.Components of depression in Parkinson disease.Late-life depression: a neuropsychiatric approach.Prevalence of depression in Parkinson's disease patients in EthiopiaMajor life events and development of major depression in Parkinson's disease patients.Depressive symptoms in Parkinson's disease and in non-neurological medical illnesses.Depression in Parkinson's disease: health risks, etiology, and treatment options.Associated and predictive factors of depressive symptoms in patients with Parkinson's disease.CBT for the treatment of depression in Parkinson's disease: a promising nonpharmacological approachNonmotor manifestations of Parkinson's disease.The course of depressive symptoms in early Parkinson's disease.Neuropsychiatric symptoms in untreated Parkinson's disease.The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease: a systematic review.Psychiatric Conditions in Parkinson Disease: A Comparison With Classical Psychiatric Disorders.The role of neurotransmitters in the development of Parkinson's disease-related psychosis.Depression in Parkinson's disease. Pharmacological characteristics and treatment.Physical Comorbidity and its Impact on Symptom Profile of Depression among Elderly Patients Attending Psychiatry Services of a Tertiary Care Hospital.Risk of incident depression in patients with Parkinson disease in the UK.Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study.Impact of Depression on Hospitalization and Related Outcomes for Parkinson's Disease Patients: A Nationwide Inpatient Sample-Based Retrospective Study.Depression in patients with high-grade glioma: results of the Glioma Outcomes Project.Affective Correlates of Psychosis in Parkinson's Disease.The assessment of depression in Parkinson's disease.
P2860
Q28143750-0D099080-E6C2-40A9-9791-7F421D4A32C0Q30585564-D94FC5D6-07E6-4F1C-BB9D-A01F12E09C47Q33704127-1CEF8822-0F77-4D70-A244-7D326783032EQ33704308-A0BE3740-12BB-4407-8984-FC25B8B9AFD5Q33861294-5EE6A856-8A69-47A0-99A8-0A533785DB34Q33917094-E6EABA73-E998-4E69-87FE-2852BD26269BQ33948520-91D0A38B-9FC3-4682-93AF-D576C8AF6B08Q34228583-57CA6E94-CF3E-47CC-8B6F-792190E6BE8CQ34302897-3CD87598-BAE3-43AA-B02A-3444F1C0A651Q34490418-F79F6CF3-7E13-4506-8AB5-A8C800DA5BADQ34574771-130CA0A3-F86C-4B83-8F02-0C3F1D0151FCQ34733143-3E6BD0B5-BC0E-4E61-9B02-76D90C58F619Q35098556-AE4E4C28-C098-4681-ACCF-1E3C93A31BF7Q35103472-BE13A73C-51F7-4D6E-A3E7-53C6C830F4DAQ35453530-DAEC368C-7AD3-4DE3-91E8-1B65BBE6A64BQ35863400-DE60FE11-E2A3-4CCF-8403-541138F8F8DFQ36008775-018217AA-EEAC-4050-B6C8-875843E2DC65Q36011226-B5DB2628-BBC7-4763-A760-FDC2207B16F1Q36374392-712205AC-5E98-45CE-960A-1584C27F133FQ36390860-748672B3-EADB-4EE9-8B22-BFAC268302D0Q36457496-3740B75A-092B-4CE1-863F-FFBFDEA6E89CQ36592312-6DE12D23-B19E-4E8F-91B3-31562E4FF8C3Q36738506-1C8848CC-D30A-4676-B41A-93F8A7081F54Q36836774-68285A20-2BE4-4365-A247-B8AA622AE3ECQ36969544-E057810B-DC2A-4972-BE56-1F859EDD016CQ37035231-A06D8A9F-6405-4F22-BB4F-C8808F99EB87Q37363919-2ED2064A-9EEF-49B6-AB68-851E70993A3CQ37457863-2D416091-5A4C-48E5-B987-BF35F8850AD0Q37714081-28FD735D-3AED-428B-9ABD-C784064AD93FQ37841542-239F0E2C-539E-46D6-8860-8221AF31A76EQ38588201-B2027778-749E-4028-883A-45854CE3AC56Q38649501-0360E7B4-223F-4161-ABBE-EFCA07CF8FF6Q39450868-A409EE9D-FE91-4186-9410-0352F674ECBFQ41440074-98FF029E-632D-4EC0-83D0-7E16BBF6CE38Q44696944-A46BC011-2768-40A9-B819-1B4C6D893920Q44820225-A6E409A1-6E2F-4718-96C1-A8E3F533D618Q45776139-F284DBD8-C4B0-4E11-81C3-AAD41E1F5BB1Q47241607-349AB2B9-6580-4962-9127-B150194D8104Q47759619-60158956-9065-4127-9441-EDBA3F9FB120Q48439754-30AB64FC-A388-4B2C-947E-238274CB1826
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Risk factors for depression in Parkinson disease.
@en
Risk factors for depression in Parkinson disease.
@nl
type
label
Risk factors for depression in Parkinson disease.
@en
Risk factors for depression in Parkinson disease.
@nl
prefLabel
Risk factors for depression in Parkinson disease.
@en
Risk factors for depression in Parkinson disease.
@nl
P50
P1433
P1476
Risk factors for depression in Parkinson disease.
@en
P304
P356
10.1001/ARCHNEUR.1997.00550170097020
P4011
8317cf5a2bc51f0456e50f6c7993e4fdc76ff95b
P577
1997-05-01T00:00:00Z